Showing results (971-980 of 1,068) with videos related to
Sort By:
Pageof 107
Data in Brief|September 16, 2022
Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitorsJean-Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuaran, et al.European Journal of Cancer (Oxford, England : 1990)|August 29, 2022
Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patientsJean-Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuaran, et al.Physical Review Letters|April 28, 2009
Shell Erosion and Shape Coexistence in (16)43S27L Gaudefroy, J M Daugas, M Hass, et al.European Heart Journal|May 4, 2015
Marfan Sartan: a randomized, double-blind, placebo-controlled trialOlivier Milleron, Florence Arnoult, Jacques Ropers, et al.Cancer Research|May 18, 2018
Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma ProgressionDhruv Kumar, Jacob New, Vikalp Vishwakarma, et al.Journal of Medical Genetics|October 18, 2013
3q27.3 microdeletional syndrome: a recognisable clinical entity associating dysmorphic features, marfanoid habitus, intellectual disability and psychosis with mood disorderJulien Thevenon, Patrick Callier, Hélène Poquet, et al.Journal of Internal Medicine|August 18, 2023
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trialSophie Dupuis-Girod, Sophie Rivière, Christian Lavigne, et al.Plos Neglected Tropical Diseases|August 28, 2020
Human plague: An old scourge that needs new answersXavier Vallès, Nils Chr Stenseth, Christian Demeure, et al.Clinical Pharmacology and Therapeutics|February 16, 2026
Building a Robust Investigator-Initiated Platform: The I-CARE ExperienceJulien Kirchgesner, Laurent Beaugerie, Cédric Baumann, et al.Circulation|February 5, 2025
Efficacy of Irbesartan in Celiprolol-Treated Patients With Vascular Ehlers-Danlos SyndromeXavier Jeunemaitre, Elie Mousseaux, Michael Frank, et al.Pageof 107